# Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.

> **NCT02005900** · PHASE3 · COMPLETED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 66 (actual)

## Conditions studied

- HIV-associated Hypertriglyceridemia
- HIV-associated Hypercholesterolemia
- HIV-associated Inflammatory State

## Interventions

- **DRUG:** Docosahexaenoic acid (DHA) administration to modulate Triglycerides in HIV patients under HAART

## Key facts

- **NCT ID:** NCT02005900
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-10
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2013-12-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005900, "Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02005900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*